• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

J&J Vision Care accepting UV research proposals

Article

Are you interested in conducting research for J&J Vision Care? The company is actively soliciting proposals for research on UV and the eye.

Jacksonville, FL-Johnson & Johnson Vision Care, Inc. (JJVCI) is now accepting research proposals related to ultraviolet (UV) radiation and the human eye. Specific areas of interest include the following topics:

• Eye health, including photoageing (cataractogenesis, presbyopia, corneal, retinal, conjunctival/limbal changes)

• Epidemiology of UV-induced ocular disease, including geographic, ethnic, and occupational study. Proposals may include the study of indoor and outdoor UV radiation. Increased risk associated with UV exposure in youth.

• Assessing the protective effect of UV-blocking contact lenses on human ocular tissues including methodology, measurement techniques, and clinical endpoints. Comparative protective effects of contact lenses and spectacles/sunglasses.

Research proposals must be submitted through the JJVCI Investigator Initiated Study (IIS) application process by contacting the clinical research administrator via e-mail at RA-VISUS-IISRequests@its.jnj.com or by calling at +1-904-443-1525. All research proposals must be submitted in English.

For additional information on JJVCI’s IIS process and policy, visit  http://www.acuvueprofessional.com/investigator-initiated-studies

Related Videos
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.